Johannes Pohlhammer

The fate of patients with intermittent claudication in the 21st century revisited – results from the CAVASIC Study

Barbara Rantner, Barbara Kollerits, Johannes Pohlhammer et al. · Scientific Reports · 2017 · 42 citations · Full text

Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study

Azin Kheirkhah, Claudia Lamina, Barbara Rantner et al. · Atherosclerosis · 2020 · 27 citations · Full text

Serum concentrations of l-arginine and l-homoarginine in male patients with intermittent claudication: A cross-sectional and prospective investigation in the CAVASIC Study

Lena Vogl, Johannes Pohlhammer, Andreas Meinitzer et al. · Atherosclerosis · 2015 · 20 citations

Cavasic Study, Prospective Investigation, Intermittent Claudication +5

High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality – The CAVASIC Study

Johannes Pohlhammer, Florian Kronenberg, Barbara Rantner et al. · Atherosclerosis · 2014 · 19 citations

Cavasic Study, Intermittent Claudication, Cardiovascular Disease +8

Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication – results from the CAVASIC Study

Barbara Rantner, Johannes Pohlhammer, Marietta Stadler et al. · Atherosclerosis · 2015 · 15 citations

Cavasic Study, Heart Failure, Cardiovascular Disease +8